| Disease | ischemia |
| Phenotype | C0678222|breast carcinoma |
| Sentences | 1 |
| PubMedID- 22899285 | To that end, this study evaluated erbb2 status using two different fda-approved in-situ hybridization methods and an fda-approved immunohistochemistry (ihc) assay in the largest cohort to date (n=84) of invasive breast carcinomas with tracked cold ischemia time. |
Page: 1